InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Highlights Promising Mpox Vaccine Data at World Vaccine Congress
Tonix Pharmaceuticals (NASDAQ: TNXP) presented preclinical data on its novel mpox vaccine candidate, TNX-801, at the World Vaccine Congress-Europe 2024. The presentation underscored the vaccine's robust tolerability and immune protection with single-dose efficacy against a monkeypox challenge, even in immunocompromised animals. TNX-801, based on an attenuated live horsepox virus, demonstrated an inability to spread in blood or tissues and showed potential to reduce transmission. Aligned…